Apologies for the tardiness of this post but I have been attempting to gather some news today.
Anyway, I read with a keen interest the piece on the front page of Financial Times about Celgene's $7 billion acquisition of Receptos and the detail surrounding the sale process. I guess it helps back up the idea that perhaps I wasn't talking nonsense after all during some of those recent sessions on Tip TV.
A cheeky financial blog with stories about deals, dealmakers and anything else I find interesting. Edited by Ben Harrington. [Disclaimer - the information on Betaville does not constitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions.]
Showing posts with label Celgene. Show all posts
Showing posts with label Celgene. Show all posts
Friday, 31 July 2015
Wednesday, 15 July 2015
What a surprise: Receptos bought for over $7 billion
US pharma group Celgene last night agreed to pay more than $7 billion for Receptos, a biopharmaceutical company.
Now I realise Ed Hammond over at Bloomberg "broke" the story about a potential sale of Receptos several months ago - here is the link: http://www.bloomberg.com/news/articles/2015-04-01/receptos-said-to-get-takeover-interest-amid-partnership-talks
Now I realise Ed Hammond over at Bloomberg "broke" the story about a potential sale of Receptos several months ago - here is the link: http://www.bloomberg.com/news/articles/2015-04-01/receptos-said-to-get-takeover-interest-amid-partnership-talks
Subscribe to:
Comments (Atom)